rs12005720
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000093.5(COL5A1):c.2646+126T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.122 in 927,386 control chromosomes in the GnomAD database, including 7,742 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.14 ( 1753 hom., cov: 32)
Exomes 𝑓: 0.12 ( 5989 hom. )
Consequence
COL5A1
NM_000093.5 intron
NM_000093.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.49
Publications
10 publications found
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- arterial disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 9-134786174-T-C is Benign according to our data. Variant chr9-134786174-T-C is described in ClinVar as Benign. ClinVar VariationId is 1257326.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.199 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A1 | NM_000093.5 | c.2646+126T>C | intron_variant | Intron 31 of 65 | ENST00000371817.8 | NP_000084.3 | ||
| COL5A1 | NM_001278074.1 | c.2646+126T>C | intron_variant | Intron 31 of 65 | NP_001265003.1 | |||
| COL5A1 | XM_017014266.3 | c.2646+126T>C | intron_variant | Intron 31 of 64 | XP_016869755.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.144 AC: 21936AN: 151868Hom.: 1750 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
21936
AN:
151868
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.118 AC: 91139AN: 775400Hom.: 5989 AF XY: 0.116 AC XY: 46843AN XY: 403004 show subpopulations
GnomAD4 exome
AF:
AC:
91139
AN:
775400
Hom.:
AF XY:
AC XY:
46843
AN XY:
403004
show subpopulations
African (AFR)
AF:
AC:
3999
AN:
19330
American (AMR)
AF:
AC:
2587
AN:
32826
Ashkenazi Jewish (ASJ)
AF:
AC:
2532
AN:
20770
East Asian (EAS)
AF:
AC:
4420
AN:
31858
South Asian (SAS)
AF:
AC:
5066
AN:
64192
European-Finnish (FIN)
AF:
AC:
7381
AN:
46924
Middle Eastern (MID)
AF:
AC:
446
AN:
4238
European-Non Finnish (NFE)
AF:
AC:
60041
AN:
518250
Other (OTH)
AF:
AC:
4667
AN:
37012
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
3971
7942
11913
15884
19855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1280
2560
3840
5120
6400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.144 AC: 21962AN: 151986Hom.: 1753 Cov.: 32 AF XY: 0.142 AC XY: 10545AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
21962
AN:
151986
Hom.:
Cov.:
32
AF XY:
AC XY:
10545
AN XY:
74300
show subpopulations
African (AFR)
AF:
AC:
8383
AN:
41458
American (AMR)
AF:
AC:
1325
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
442
AN:
3464
East Asian (EAS)
AF:
AC:
807
AN:
5172
South Asian (SAS)
AF:
AC:
347
AN:
4806
European-Finnish (FIN)
AF:
AC:
1675
AN:
10578
Middle Eastern (MID)
AF:
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8636
AN:
67930
Other (OTH)
AF:
AC:
307
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
964
1929
2893
3858
4822
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
466
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.